International Cardio-Oncology Society – IC-OS shared on LinkedIn:
“The Future of Cardio-Oncology is looking bright!
Every year at GCOS, we invite three young researchers to present their work to the broader cardio-oncology community – with the most promising research winning the Young Investigator Award.
This year’s Young Investigators are:
- Joseph Wallins – ‘Early dexrazoxane administration is associated with reduced risk of cardiotoxicity in sarcoma patients receiving anthracycline therapy’
- Mandeep Singh – ‘Glucagon-Like Peptide 1 Receptor Agonists and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Receiving Cyclin Dependent Kinase 4/6 Inhibitor Therapy for Metastatic Breast Cancer’
- Inbar Nardi Agmon – ‘Upfront Immune Checkpoint Inhibitors and Long-Term Risk of Major Adverse Cardiovascular Events: A Population-Based Propensity-Matched Cohort Study’
Thank you to all three of these researcher for their amazing contributions and presentations.
The winners will be announced tomorrow morning.”
Other articles about IC-OS on OncoDaily.
